NCT05435495 2026-03-18
Mechanisms of Resistance to PSMA Radioligand Therapy
University of California, San Francisco
Recruiting
Clinical Trials
12 trialsNCT02657863 2025-12-23
Cancer DNA Detection in Blood and Urine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Completed
NCT07054346 2025-12-01
LUTACT
University of California, San Francisco
Phase 1 Recruiting
NCT04167969 2025-10-14
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
NCT02869282 2025-09-17
CHEMOPROST
Institut Bergonié
Withdrawn
NCT06435546 2025-09-16
AdOTAC
Institut de Cancérologie de Lorraine
Phase NA Recruiting
NCT05141383 2025-09-08
HOPE
Institut Curie
Phase NA Completed
NCT05011188 2025-08-27
FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer
University of California, San Francisco
Phase 1/2 Active not recruiting
NCT06942104 2025-07-18
Imaging of Solid Tumors Using 18F-TRX
University of California, San Francisco
Phase 1 Recruiting
NCT04581109 2025-07-10
EPIDROP
University Hospital, Montpellier
Phase NA Recruiting
NCT06904313 2025-06-04
Ultralow Dose PET Imaging for PSMA Expression
Nuclear Imaging Institute
Phase 2 Recruiting
NCT05819827 2025-04-27
Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
Mayo Clinic
Terminated